When initiating VICTOZA, consider reducing the dose of concomitantly administered insulin secretagogues (such as sulfonylureas) to reduce the risk of hypoglycemia [see  WARNINGS AND PRECAUTIONS and ADVERSE REACTIONS].
No dose adjustment is recommended for patients with renal impairment.
